http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2505321-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e9b6ed2debcbd5188dc01b0be9398f16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5b927b82c65b8a4da883a06437d62b8
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M25-092
filingDate 2012-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7471bce7c8c8e7af9c9a76772872efc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8383fb7d04cd92aaf8d037e0b493bd4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e44c69a66e5ced0997b435ee23ea92ca
publicationDate 2014-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2505321-C1
titleOfInvention Method for detoxification in patients suffering obstructive jaundice of various origins
abstract FIELD: medicine. n SUBSTANCE: ultrasound-assisted percutaneous transhepatic biliary drainage is followed by an infusion therapy that is derived from patient's body weight, sodium, glucose, urea with underlying hepatic passage and blood bilirubin recovery. The infusion therapy volume is derived by formula: INFUSION THERAPY VOLUME=(PLASMA OSMOLARITY+BLOOD BILIRUBIN)/15000×BODY WEIGHT, wherein: plasma osmolarity (mmole/l)=Na (mmole/l) * 1.86 + glucose (mmole/l) + urea (mmole/l) +10, mosm/l; bilirubin, mcmole/l; m - body weight, kg; 15000 is an experimental number. n EFFECT: method provides the fast reduction of obstructive jaundice ensured by driving the adequate infusion therapy according to the individual water and electrolyte metabolism and bilirubin. n 4 dwg, 1 ex
priorityDate 2012-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2240116-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1271519-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2349322-C2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60109
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46891807
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25199857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1176
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454493330
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6148
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533724
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451784107
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00634
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483213

Total number of triples: 50.